These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7609672)

  • 1. Hemostatic concomitants of syndrome X.
    McCarty MF
    Med Hypotheses; 1995 Mar; 44(3):179-93. PubMed ID: 7609672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.
    Sakkinen PA; Wahl P; Cushman M; Lewis MR; Tracy RP
    Am J Epidemiol; 2000 Nov; 152(10):897-907. PubMed ID: 11092431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombophilic factors in patients with Syndrome X.
    Terpos E; Athanasiou A; Tsoukala C; Anastasopoulou J; Kyriakidis M; Karafoulidou A
    Thromb Res; 2000 Mar; 97(6):525-7. PubMed ID: 10766649
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease.
    Pearson TA; LaCava J; Weil HF
    Am J Clin Nutr; 1997 May; 65(5 Suppl):1674S-1682S. PubMed ID: 9129509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic parameters and vascular risk.
    Juhan-Vage I
    Atherosclerosis; 1996 Jul; 124 Suppl():S49-55. PubMed ID: 8831916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.
    Meigs JB; Mittleman MA; Nathan DM; Tofler GH; Singer DE; Murphy-Sheehy PM; Lipinska I; D'Agostino RB; Wilson PW
    JAMA; 2000 Jan; 283(2):221-8. PubMed ID: 10634338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hormone replacement therapy on hemostatic cardiovascular risk factors.
    Andersen LF; Gram J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):283-9. PubMed ID: 9988788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN.
    Sowers M; Derby C; Jannausch ML; Torrens JI; Pasternak R
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4904-10. PubMed ID: 14557472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic factors as triggers of cardiovascular events.
    Rosito GB; Tofler GH
    Cardiol Clin; 1996 May; 14(2):239-50. PubMed ID: 8724556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.
    Mansfield MW; Heywood DM; Grant PJ
    Circulation; 1996 Nov; 94(9):2171-6. PubMed ID: 8901668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long- and Short-term Exposure to Air Pollution and Inflammatory/Hemostatic Markers in Midlife Women.
    Green R; Broadwin R; Malig B; Basu R; Gold EB; Qi L; Sternfeld B; Bromberger JT; Greendale GA; Kravitz HM; Tomey K; Matthews K; Derby CA; Jackson EA; Green R; Ostro B
    Epidemiology; 2016 Mar; 27(2):211-20. PubMed ID: 26600256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the hemostatic system in pathogenesis of atherosclerosis as the main etiology of coronary ischemia] [corrected].
    Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
    Pol Merkur Lekarski; 2004 May; 16(95):465-7. PubMed ID: 15518428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of atherothrombotic disorders: a clinician's view.
    Grant PJ
    J Thromb Haemost; 2003 Jul; 1(7):1381-90. PubMed ID: 12871271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases.
    Chrusciel P; Goch A; Banach M; Mikhailidis DP; Rysz J; Goch JH
    Med Sci Monit; 2009 Oct; 15(10):RA203-208. PubMed ID: 19789523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome.
    Godsland IF; Crook D; Proudler AJ; Stevenson JC
    J Clin Endocrinol Metab; 2005 Jan; 90(1):190-7. PubMed ID: 15494459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review.
    Mina A; Favaloro EJ; Koutts J
    Semin Thromb Hemost; 2007 Nov; 33(8):798-809. PubMed ID: 18175285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic and metabolic variables in women with polycystic ovary syndrome.
    Dahlgren E; Janson PO; Johansson S; Lapidus L; Lindstedt G; Tengborn L
    Fertil Steril; 1994 Mar; 61(3):455-60. PubMed ID: 8137966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic risk factors for cardiovascular diseases.
    Koenig W
    Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity.
    Primrose JN; Davies JA; Prentice CR; Hughes R; Johnston D
    Thromb Haemost; 1992 Oct; 68(4):396-9. PubMed ID: 1448769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.